OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis
Xiang Zhang, Ming‐Hua Zheng, Dehua Liu, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 6
Xiang Zhang, Ming‐Hua Zheng, Dehua Liu, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 6
Showing 6 citing articles:
Reply to “Plasma metabolomics promises to facilitate precise prevention of MASH and mortality from liver disease”
Qingxia Huang, Huiru Tang, Xin Gao, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 1
Qingxia Huang, Huiru Tang, Xin Gao, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 1
Unveiling NLR pathway signatures: EP300 and CPN60 markers integrated with clinical data and machine learning for precision NASH diagnosis
Marwa Matboli, Noha E. El-Attar, Ibrahim Abdelbaky, et al.
Cytokine (2025) Vol. 188, pp. 156882-156882
Closed Access
Marwa Matboli, Noha E. El-Attar, Ibrahim Abdelbaky, et al.
Cytokine (2025) Vol. 188, pp. 156882-156882
Closed Access
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
Xiang Zhang, Harry Cheuk-Hay Lau, Jun Yu
Pharmacological Reviews (2025) Vol. 77, Iss. 2, pp. 100018-100018
Open Access
Xiang Zhang, Harry Cheuk-Hay Lau, Jun Yu
Pharmacological Reviews (2025) Vol. 77, Iss. 2, pp. 100018-100018
Open Access
Cytokeratin 18 fragment in liver inflammation and fibrosis: Systematic review and meta-analysis
Junzhao Ye, Jiaming Lai, Ling Luo, et al.
Clinica Chimica Acta (2025), pp. 120147-120147
Closed Access
Junzhao Ye, Jiaming Lai, Ling Luo, et al.
Clinica Chimica Acta (2025), pp. 120147-120147
Closed Access
The crucial function of gut microbiota on gut-liver repair
Yamei Wang, Yan He, Qianqian Zheng, et al.
hLife (2025)
Open Access
Yamei Wang, Yan He, Qianqian Zheng, et al.
hLife (2025)
Open Access
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
Maria V. Bourganou, Maria Chondrogianni, Ioannis Kyrou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1589-1589
Open Access
Maria V. Bourganou, Maria Chondrogianni, Ioannis Kyrou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1589-1589
Open Access
The promise of incretin-based pharmacotherapies for metabolic dysfunction-associated fatty liver disease
Harendran Elangovan, Jenny E. Gunton, Ming‐Hua Zheng, et al.
Hepatology International (2025)
Open Access
Harendran Elangovan, Jenny E. Gunton, Ming‐Hua Zheng, et al.
Hepatology International (2025)
Open Access
